Compare Johnson & Johnson (JNJ) vs Vanguard Dividend Appreciation Index Fund ETF (VIG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Vanguard Dividend Appreciation Index Fund ETF — how do they compare? Johnson & Johnson trades at $260.7 (market cap $626.09B), while Vanguard Dividend Appreciation Index Fund ETF trades at $246.64. The key difference: Johnson & Johnson pays a 2.06% dividend while Vanguard Dividend Appreciation Index Fund ETF pays none. Which is the better fit depends on your goals.
| JNJ | VIG | |
|---|---|---|
Market Cap | $626.09B | — |
Volume | 6,156,228 | — |
Sector | Health | — |
52-Week High | $267.24 | $245.79 |
52-Week Low | $172.78 | $208.67 |
Enterprise Value | $654.37B | — |
Dividend Yield | 2.06% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $260.88, down 0.36% today, with a bullish technical signal supported by moving averages. The stock shows strong profitability with a net margin of 21.48% and ROE of 25.74%, though valuations like a P/E of 30.14 appear elevated. Recent earnings beat expectations in Q1 and Q2 2026, and the company maintains a 64-year dividend growth streak, with analyst consensus leaning bullish.
Outlook remains positive with a consensus price target of $284.50, offering potential upside, but risks include legal challenges and high debt-to-asset ratio of 24.06% in 2025. Investors benefit from steady dividends and defensive positioning in healthcare, though valuation multiples may limit near-term gains amid economic uncertainty.
VIG trades at $246.19, up 0.16% on the day, with a bullish technical signal from moving averages but overbought RSI readings. The ETF focuses on dividend growth stocks, with a 1.5% yield and a 20-year streak of dividend increases. Recent news highlights its role in retirement income strategies and comparisons with peers like SCHD.
The outlook remains positive for long-term investors seeking dividend growth and lower risk, though high RSI suggests near-term consolidation. Risks include market volatility and interest rate sensitivity, but institutional interest and a quality stock selection process support its defensive appeal.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Vanguard Dividend Appreciation Index Fund ETF
The advisor employs an indexing investment approach designed to track the performance of the index, which consists of common stocks of companies that have a record of increasing dividends over time. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VIG →
